Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: SSP who wrote (25321)	2/7/2000 9:18:00 AM
From: OFW	Respond to of 150070

AIRG Medicare News Out . . . DALLAS--(BUSINESS WIRE)--Feb. 7, 2000--Airtech International Group, Inc. (OTCBB:AIRG) announced today the Company is starting their national sales program of the Model S-950 portable air sterilization unit to Medicare recipients across America. Airtech Medicare Consultant Glenn Shimmel stated, "Medicare has given Airtech a green light to start sales based on a Preliminary Non-Covered Code for Durable Medical Equipment. Following Airtech's submittal of additional technical information, the next step would include issuance of a Permanent Billing Code. Currently no air sterilization technology is available throughout the Medicare system." Airtech will offer their product through the national 10,000 + DME/HME network. Airtech will start preliminary sales utilizing this non-assigned code. Due to the enormous size of this market and the financial impact to Medicare of this type of approval the Administration may require more technical and scientific information for research and compliance during the approval process. Airtech CEO C.J. Comu, commented, "the Airsopure Model S-950 has so many more clinical applications beyond the Medicare system, the entire home health care market is also wide open." Airtech's projections are to sell the first 20,000 units of the Model S-950 in Phase I of the sales process. Airtech will commence their marketing and sales efforts ramping up over the next quarter, to DME's, HME's, hospice care facilities, and home health care providers. Airtech submitted a formal application to the Medicare Administration on October 12, 1999 applying for approval of the Airsopure Model S-950 air sterilization system. Approval will provide the physician and patient access to the most efficient portable in home sterilization device available today. Medicare covers approximately forty million Americans, many with serious cardio and respiratory health problems. Prescribing the S-950, based on medical necessity will afford the patient an adjunct to traditional medical treatment, prescriptions and drugs. Nationwide, many physicians and health care Professional have validated the technology and the need for Medicare approval. Today, Airtech's primary focus is on schools, hotels, office buildings, casinos and medical facilities. Airtech International Group Inc., (www.airtechgroup.com), is a publicly traded company under the symbol (OTCBB:AIRG). Airsopure, Inc., (www.airsopure.com) is a wholly owned subsidiary of Airtech, was founded in 1997 and has a number of franchisees throughout the United States, Canada and Europe. Investors may obtain more information by contacting the Company at Tel: 972/960-9400, Fax: 972/960-9395. The Company first achieved market recognition with its air purification technology by providing a simple solution using advanced technology and engineering allowing smokers and non-smokers to co-exist in restaurants and bars. Its corporate customers include: Southwest Airlines, Alphagraphic's, El Chico's, Bennigan's, TGI Friday's, Del Frisco's Double Eagle Steakhouses, Sullivan's, and many other companies. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements contained in this document which are not historical fact are forward-looking statements based upon management's current expectations that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward looking statements. These risks are described in the Company's Form 10-KSB for the fiscal year ending May 31, 1999 filed with the Securities Exchange Commission. --30--LS/na* CONTACT: Airtech International Group Inc. C.J. Comu, 972/960-9400